COVID-19: Keep up to date with the latest pharmaceutical and healthcare news as the pandemic evolves

Space invaders

Next-generation cell and gene therapies are spurring demand for manufacturing space in key life sciences clusters
The rise of patient 2.0

Janssen’s Emily Bone talks about modern patient engagement evolution and why it is the driving force for a brave new era
Pharma goes pop

After centuries hidden away in the medicine cabinet our industry has finally entered the mainstream. Editor John Pinching fnds out how pharma has been injected into the collective public consciousness forever
Talking about an evolution

A new healthcare universe has been expanding with strategic household branding, omnipresent metahealth and genuine soul at the heart of it
Come together

Abbey Road was the setting and music was the theme as the rare disease community convened to celebrate Rare Disease Day, raise awareness of Pompe disease and lay down a catchy tune

News

View all

NICE recommends app-based treatment for insomnia over sleeping pills

Thousands usually prescribed sleeping pills could be offered app-based treatment

20th May 2022

Birmingham research shows promise for spinal cord injury patients

Scientists demonstrated that AZD1236 halts oedema while reducing spinal cord breakdown at site of injury

20th May 2022

Simple blood test could save thousands from bowel cancer

Comparisons with other tests available have shown that blood test has greater sensitivity for the detection of bowel cancer

19th May 2022

The Baillie Gifford Pandemic Science Hub launched to fight lung disease

Gifford is supporting the launch with a philanthropic donation of £14.7m

19th May 2022

Curebase and Flow Neuroscience launch clinical trial to test at-home headset for depression

Device delivers currents to the brain to restore activity usually lowered in depression patients

18th May 2022

Web Exclusives

View all

Will remote pharma GMP auditing cease after COVID?

The past two years has seen auditing activity move increasingly online and some auditors are now claiming the tools they developed during the pandemic could offer a permanent solution, but deeper analysis shows that not all clients are convinced

The power of patient partnerships

John James OBE, Chief Executive of the Sickle Cell Society, talks about the power of engaging patients

Going for gold

So, you’re considering entering the Patient Partnership Index? Here's our guide to writing a winning entry for the Patient Partnership Index

Entries open for the Patient Partnership Index 2022

The Patient Partnership Index – developed by health communications agency Ovid Health in partnership with the PharmaTimes – aims to showcase best practice and raise standards across industry

Magazine

View more from the latest edition

That’s democracy

Democratising clinical trials among patient groups must become a pivotal target throughout the healthcare ecosystem

Data with destiny

How we recognise and respond to disease is evolving – our future is inseparable from it

The incredible journey

Hayley Scutts reflects on an inspiring and intrepid route to a nursing career – which started as a patient

Seizing the zeitgeist

Hannah Riley talks about women’s health, the contraception gap and the importance of owning the narrative

New balance

Levelling up on prescribing, acting on variations in prescribing practice and solving health inequalities have provided the NHS with an era-specific agenda

Awakenings

Conscious digital transformation across healthcare and the NHS is gradually happening but significant challenges are afoot

Space invaders

Next-generation cell and gene therapies are spurring demand for manufacturing space in key life sciences clusters

The rise of patient 2.0

Janssen’s Emily Bone talks about modern patient engagement evolution and why it is the driving force for a brave new era

Thought Leadership

View all

Just-in-time Labeling: Short-term Fix Or Long-term Fixture For Clinical Trials?

Despite Just-In-Time (JIT) production often being the preferred approach in clinical trial supply, it has taken a global pandemic for many organizations to make it a reality. Now, as we look to the future, PRISYM ID’s Bob Bowdish explains why these practices may be here to stay.

Native advertising is exploding across healthcare, have you jumped in?

In the last 2 years, and accelerated by Covid, native advertising has exploded across healthcare for DTC and HCP marketing. Native ads have been adopted by all healthcare industries including pharma, device, health systems, retailers, pharmacies, payers, and the gamut of regional service providers. But there are still a handful of advertiser holdouts, and they are missing out on highly engaged audiences.

Improving waste management in pharmaceutical manufacturing

By Grace Oldham, Head of Business Development, at Axil Integrated Services

A life in a day

How immersive learning experiences can support and elevate patient-centricity goals in the pharma industry

Webinars

View all

Patient Perspectives to Improve Retention with eConsent

Tuesday, 22 February 2022 - 4:00 pm

With Tufts reporting that the average number of patient dropouts for clinical trials remains near 30%, it is clear that there is still much to be done towards improving retention¹.

Andrew Mackinnon, Digital Trial Operations Lead, Medable

FREE | ATTEND

Focusing on Patient-centricity for the Future of Pharma

Wednesday, 21 July 2021 - 2:00 pm

In healthcare, the patient voice is arguably the most important. Services and care work best when a person’s needs are fully met and they feel heard, respected and valued.

Mark Doyle, co-founder of The Method and creator of A Life in a Day

FREE | ATTEND